GGrantIndex
Sort

48,018 grants matching immunotherapy

Immunologic Monitoring and Cellular Products Laboratory

$532,212
Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA

Neurologic Alterations in Alzheimer's Disease

$532,149
Bradley T Hyman · Massachusetts General Hospital · R01 · FY2009 · AG

Contribution of Cerebral Iron Load to Cognitive Function in Older Adults with High Risk to Develop Alzheimer's Disease

$532,000
Ye Qiao · Johns Hopkins University · R01 · FY2022 · AG

Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma

$531,996
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

The role of antibody and the Fc neonatal receptor in transmitted/founder strain selection

$531,993
Donald N Forthal · University Of California-Irvine · R01 · FY2019 · AI

The role of antibody and the Fc neonatal receptor in transmitted/founder strain selection

$531,993
Donald N Forthal · University Of California-Irvine · R01 · FY2017 · AI

Cancer Pharmacology

$531,895
Lorraine J Gudas · Weill Medical Coll Of Cornell Univ · T32 · FY2020 · CA

Whitlockite nanoparticle-based immunotherapy for bone metastasis

$531,867
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2023 · CA

Whitlockite nanoparticle-based immunotherapy for bone metastasis

$531,867
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2022 · CA

Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy

$531,772
Allon Moshe Klein · Harvard Medical School · R01 · FY2019 · CA

Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex

$531,728
Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2018 · GM

Exploring the dynamic tumor-immune ecosystem of breast cancer in heterogeneous tumor microenvironments

$531,693
Stacey Deleria Finley · University Of Southern California · U01 · FY2025 · CA

Human Herpesvirus 6B in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome pathogenesis: temporal analysis of viral reactivation and immunity to elucidate cause vs effect

$531,652
Eliana Lacerda · London Sch/Hygiene & Tropical Medicine · R01 · FY2022 · AI

Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer

$531,608
Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2023 · CA

Naive T cell depletion to prevent graft-versus-host disease

$531,554
Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2015 · HL

Career Development in Pediatric and Medical Oncology

$531,466
Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2016 · CA

Unraveling the Pathophysiology of Neurotoxicity Induced by CAR T-cells

$531,448
Christopher A Pennell · University Of Minnesota · R01 · FY2023 · CA

Sexual Dimorphism in T Cell Exhaustion and Bladder Cancer

$531,447
Zihai Li · Cedars-Sinai Medical Center · P01 · FY2023 · CA

The Evaluation of Novel Therapeutics for Genitourinary Malignancies

$531,416
William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA

Immunologic Responses to Cow's Milk Proteins in IgE-mediated Cow's Milk Allergy

$531,407
Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2011 · AI

Project 1: Physical modeling and dynamics of tumor cell migration mechanics

$531,383
David J Odde · University Of Minnesota · U54 · FY2020 · CA

Investigating mitochondrial networks as a critical determinant of response to antibody drug conjugates in advanced NSCLC

$531,379
Aaron Elliott Lisberg · University Of California Los Angeles · R01 · FY2025 · CA

Structural surfaceomics to probe conformation-selective immunotherapy targets

$531,377
Arun P. Wiita · University Of California, San Francisco · R01 · FY2025 · CA

Preclinical Development of First-in-Class GSTO1 Degraders for Colorectal Cancer

$531,356
Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

MAINLINE HEALTH CCOP

$531,351
Lankenau Institute For Medical Research · U10 · FY2002 · CA